964 related articles for article (PubMed ID: 9603117)
1. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.
Seemungal TA; Donaldson GC; Paul EA; Bestall JC; Jeffries DJ; Wedzicha JA
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1418-22. PubMed ID: 9603117
[TBL] [Abstract][Full Text] [Related]
2. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.
Seemungal TA; Donaldson GC; Bhowmik A; Jeffries DJ; Wedzicha JA
Am J Respir Crit Care Med; 2000 May; 161(5):1608-13. PubMed ID: 10806163
[TBL] [Abstract][Full Text] [Related]
3. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels.
Wedzicha JA; Seemungal TA; MacCallum PK; Paul EA; Donaldson GC; Bhowmik A; Jeffries DJ; Meade TW
Thromb Haemost; 2000 Aug; 84(2):210-5. PubMed ID: 10959691
[TBL] [Abstract][Full Text] [Related]
4. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
5. Clinical predictors of exacerbation frequency in chronic obstructive pulmonary disease.
Brusse-Keizer M; van der Palen J; van der Valk P; Hendrix R; Kerstjens H
Clin Respir J; 2011 Oct; 5(4):227-34. PubMed ID: 21106031
[TBL] [Abstract][Full Text] [Related]
6. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
7. AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD.
Kuna P; Jenkins M; O'Brien CD; Fahy WA
Respir Med; 2012 Apr; 106(4):531-9. PubMed ID: 22197578
[TBL] [Abstract][Full Text] [Related]
8. Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare.
Llor C; Molina J; Naberan K; Cots JM; Ros F; Miravitlles M;
Int J Clin Pract; 2008 Apr; 62(4):585-92. PubMed ID: 18266710
[TBL] [Abstract][Full Text] [Related]
9. Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.
Donaldson GC; Law M; Kowlessar B; Singh R; Brill SE; Allinson JP; Wedzicha JA
Am J Respir Crit Care Med; 2015 Oct; 192(8):943-50. PubMed ID: 26151174
[TBL] [Abstract][Full Text] [Related]
10. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
11. Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year.
Xu W; Collet JP; Shapiro S; Lin Y; Yang T; Wang C; Bourbeau J
Eur Respir J; 2010 May; 35(5):1022-30. PubMed ID: 19897555
[TBL] [Abstract][Full Text] [Related]
12. The association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysis.
Martin AL; Marvel J; Fahrbach K; Cadarette SM; Wilcox TK; Donohue JF
Respir Res; 2016 Apr; 17():40. PubMed ID: 27084761
[TBL] [Abstract][Full Text] [Related]
13. The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease: a multicentre, randomised controlled trial.
Osadnik CR; McDonald CF; Miller BR; Hill CJ; Tarrant B; Steward R; Chao C; Stodden N; Oliveira CC; Gagliardi N; Holland AE
Thorax; 2014 Feb; 69(2):137-43. PubMed ID: 24005444
[TBL] [Abstract][Full Text] [Related]
14. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
[TBL] [Abstract][Full Text] [Related]
15. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
[TBL] [Abstract][Full Text] [Related]
16. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
[TBL] [Abstract][Full Text] [Related]
17. American translation, modification, and validation of the St. George's Respiratory Questionnaire.
Barr JT; Schumacher GE; Freeman S; LeMoine M; Bakst AW; Jones PW
Clin Ther; 2000 Sep; 22(9):1121-45. PubMed ID: 11048909
[TBL] [Abstract][Full Text] [Related]
18. Muscle weakness, health status and frequency of exacerbations in chronic obstructive pulmonary disease.
Ansari K; Keaney N; Taylor I; Burns G; Farrow M
Postgrad Med J; 2012 Jul; 88(1041):372-6. PubMed ID: 22388793
[TBL] [Abstract][Full Text] [Related]
19. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.
Donaldson GC; Seemungal TA; Bhowmik A; Wedzicha JA
Thorax; 2002 Oct; 57(10):847-52. PubMed ID: 12324669
[TBL] [Abstract][Full Text] [Related]
20. Association of chronic nasal symptoms with dyspnoea and quality-of-life impairment in chronic obstructive pulmonary disease.
Caillaud D; Chanez P; Escamilla R; Burgel PR; Court-Fortune I; Nesme-Meyer P; Deslee G; Perez T; Pinet C; Roche N;
Respirology; 2014 Apr; 19(3):346-52. PubMed ID: 24330257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
